skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:022520/0150   Pages: 115
Recorded: 04/08/2009
Attorney Dkt #:11987-00014-US
Conveyance: MERGER (SEE DOCUMENT FOR DETAILS).
Total properties: 16
1
Patent #:
Issue Dt:
01/02/2007
Application #:
10181051
Filing Dt:
06/24/2002
Publication #:
Pub Dt:
08/14/2003
Title:
SUBSTITUTED OXAZOLIDINONES AND THEIR USE IN THE FIELD OF BLOOD COAGULATION
2
Patent #:
Issue Dt:
08/03/2010
Application #:
10481297
Filing Dt:
06/28/2004
Publication #:
Pub Dt:
12/02/2004
Title:
SUBSTITUTED OXAZOLIDINONES FOR COMBINATIONAL THERAPY
3
Patent #:
NONE
Issue Dt:
Application #:
10538342
Filing Dt:
06/05/2006
Publication #:
Pub Dt:
06/28/2007
Title:
Method for producing 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
4
Patent #:
Issue Dt:
Application #:
10580711
Filing Dt:
05/18/2007
Publication #:
Pub Dt:
01/31/2008
Title:
Process for the Preparation of a Solid, Orally Administrable Pharmaceutical Composition
5
Patent #:
Issue Dt:
04/01/2008
Application #:
11032815
Filing Dt:
01/10/2005
Publication #:
Pub Dt:
08/18/2005
Title:
PREPARATION PROCESS
6
Patent #:
NONE
Issue Dt:
Application #:
11317720
Filing Dt:
12/23/2005
Publication #:
Pub Dt:
02/01/2007
Title:
Solid, modified-release pharmaceutical dosage forms which can be administered orally
7
Patent #:
Issue Dt:
09/22/2009
Application #:
11460529
Filing Dt:
07/27/2006
Publication #:
Pub Dt:
11/16/2006
Title:
SUBSTITUTED OXAZOLIDINONES AND THEIR USE IN THE FIELD OF BLOOD COAGULATION
8
Patent #:
Issue Dt:
01/10/2017
Application #:
11883218
Filing Dt:
07/16/2008
Publication #:
Pub Dt:
01/01/2009
Title:
Prevention and Treatment of Thromboembolic Disorders
9
Patent #:
Issue Dt:
08/18/2009
Application #:
11932082
Filing Dt:
10/31/2007
Publication #:
Pub Dt:
04/17/2008
Title:
SUBSTITUTED OXAZOLIDINONES AND THEIR USE IN THE FIELD OF BLOOD COAGULATION
10
Patent #:
Issue Dt:
04/26/2011
Application #:
11992396
Filing Dt:
06/20/2008
Publication #:
Pub Dt:
02/05/2009
Title:
2-AMINOETHOXYACETIC ACID DERIVATIVES AND THEIR USE
11
Patent #:
NONE
Issue Dt:
Application #:
11999445
Filing Dt:
12/04/2007
Publication #:
Pub Dt:
05/08/2008
Title:
Novel cytostatic conjugates with integrin ligands
12
Patent #:
Issue Dt:
09/08/2009
Application #:
12027553
Filing Dt:
02/07/2008
Publication #:
Pub Dt:
08/21/2008
Title:
SUBSTITUTED OXAZOLIDINONES AND THEIR USE IN THE FIELD OF BLOOD COAGULATION
13
Patent #:
Issue Dt:
05/29/2012
Application #:
12089095
Filing Dt:
06/20/2008
Publication #:
Pub Dt:
06/17/2010
Title:
NOVEL POLYMORPHOUS FORM OF 5-CHLORO-N-({(5S)-2-OXO-3[4-(3-OXO-4-MORPHOLINYL)-PHENYL]-1,3-OXAZOLIDINE-5-YL}-METHYL)-2-THIOPHENE CARBOXAMIDE
14
Patent #:
Issue Dt:
11/19/2013
Application #:
12089148
Filing Dt:
07/02/2008
Publication #:
Pub Dt:
06/17/2010
Title:
SOLID ORALLY ADMINISTERABLE PHARMACEUTICAL DOSAGE FORMS WITH RAPID ACTIVE PRINCIPLE RELEASE
15
Patent #:
NONE
Issue Dt:
Application #:
12089169
Filing Dt:
06/05/2008
Publication #:
Pub Dt:
12/11/2008
Title:
Combination Therapy Comprising Substituted Oxazolidinones for the Prevention and Treatment of Cerebral Circulatory Disorders
16
Patent #:
NONE
Issue Dt:
Application #:
12089650
Filing Dt:
07/02/2008
Publication #:
Pub Dt:
06/24/2010
Title:
MICROANGIOPATHY TREATMENT AND PREVENTION
Assignor
1
Exec Dt:
12/30/2008
Assignee
1
KAISER-WILHELM-ALLEE
BUILDING Q 18
LEVERKUSEN, GERMANY D-51368
Correspondence name and address
CONNOLLY BOVE LODGE & HUTZ LLP
1007 NORTH ORANGE STREET
P.O. BOX 2207
WILMINGTON, DE 19899

Search Results as of: 05/09/2024 04:50 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT